CONTACT US

Circa Group Pty Ltd
Bio21 Molecular Science
& Biotechnology Institute
30 Flemington Road, Parkville
VIC 3052 Australia
Twitter @circagroup

Tony Duncan
Chief Executive Officer
Tony.Duncan@circagroup.com.au

Fabien Deswarte
Business Development Manager
Fabien.Deswarte@circasc.com

c/o Bio 21, Flemington Road
Melbourne
Australia

+61 419 303 117

Circa Group is converting waste biomass into advanced biochemical materials.

News

PRESS RELEASE – CIRCA RECEIVES GREEN LIGHT TO SELL NON-TOXIC, BIO-BASED AND BIODEGRADABLE SOLVENT IN EU

Simm Design

click here to view press release

YORK, UK – 10 December 2018 – Biotechnology company Circa Group has received authorisation from the European Chemicals Agency (ECHA) to manufacture or import up to 100 tonnes/year of its bio-based solvent CyreneTM in the European Union, after receiving REACH Annex VIII approval.

A chiral dipolar aprotic solvent, CyreneTM was developed in conjunction with the Green Chemistry Centre of Excellence (GCCE) at the University of York. CyreneTM is a two step conversion of waste biomass, produced at Circa's large-scale prototype plant, built in partnership with pulp and paper company Norske Skog in Tasmania, Australia.

Solvent regulation is increasingly focused on restricting hazardous chemicals to manage their risk to people animals and the environment. In the EU, widely used solvents such as NMP, DMF and DMAc are on the candidate list of Substances of Very High Concern (SVHC) due to their reprotoxicity. In addition, a new restriction on NMP was adopted earlier this year, meaning that after May 2020, use will be further restricted and it will not be able to be manufactured or used in the EU unless operational conditions are maintained to ensure that exposure to workers is below specified levels.